Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fenofibrate and Pharmacogenetic Impact in Dyslipidemia (FPI)

This study has been completed.
Laval University
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute Identifier:
First received: January 31, 2008
Last updated: December 1, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)